πΊπΈ
United States Β· US Β· US:84141-025_20832f43-4967-4ced-ac62-989dbe66c40f
REDEMPLO
Orange BookUNIISPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerArrowhead Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeβ
Dispensingβ
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs Β· 1
- ndc1184141025011 SYRINGE, GLASS in 1 CARTON (84141-025-01) / 1 mL in 1 SYRINGE, GLASS
Annotations
UNII (FDA Substance ID)
XG9ARL6P25
PLOZASIRAN
Orange Book
N219947
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "XG9ARL6P25",
"rxcui": null,
"inchikey": null,
"display_name": "PLOZASIRAN",
"substance_type": "nucleicAcid",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"7fd37993-f85a-4af1-8bbe-133299f226ed": {
"match": "brand_token",
"title": "REDEMPLO (PLOZASIRAN) INJECTION, SOLUTION [ARROWHEAD PHARMACEUTICALS, INC.]",
"spl_version": "3",
"published_date": "2025-11-25"
}
},
"productid": "84141-025_20832f43-4967-4ced-ac62-989dbe66c40f",
"productndc": "84141-025",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "219947",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML)",
"product_no": "001",
"approval_date": "Nov 18, 2025"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "PLOZASIRAN",
"proprietary_name": "REDEMPLO",
"active_ingred_unit": "mg/.5mL",
"application_number": "NDA219947",
"marketing_category": "NDA",
"nonproprietary_name": "plozasiran",
"start_marketing_date": "20251119",
"active_numerator_strength": "25"
}Access this data programmatically
Query REDEMPLO and 610,000+ other drug records through a single REST API β with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.